High Risk, High Reward: What Your R21 Should Be 

60 Minute On-Demand Webinar. Available in CD, MP4 or PDF Transcript

or Call 1-800-303-0129 ext. 506

You have your research idea ready to go, so your next stop is an R01 grant application, right? Not so fast. There may be a better funding mechanism that fits your needs more precisely.

NIH specifically designed the R21 to support high risk/high reward research. And the agency formulated the review criteria for these applications to make sure those proposals receive the funding they need.

This webinar will provide you with the tools to recognize the differences between the R01 and the R21, including the money and time involved. Plus, our expert presenter will give you the strategies that will help your application succeed with reviewers.

5 Key Take-Aways:

  • Make sure the R21 is right for you — Master the fundamentals of choosing the right grant
  • Streamline your application: Indicate high risk/high reward without exceeding your page count
  • R21s offer limited funding … How to make sure scope doesn’t exceed your means
  • 6 Critical elements every NIH reviewer looks for in your R21
  • You get your R21 — Here’s how to leverage it for an R01


  • CD-Rom with PDF Handouts — Price: $197 $89!
  • MP4 File with PDF Handouts — Price: $197 $89!
  • PDF Transcript with Handouts — Price: $197 $89!

Offer valid on NEW orders only.

Meet Your Presenter:

Dr. Dorothy Lewis, Professor, Internal Medicine, Infectious Diseases at the University of Texas Health Science Center has a 26-year history of writing grant applications. Her successful track record for winning them has given her a valuable “in the trenches” perspective that can benefit you, at whichever stage you find yourself. She received her PhD in Microbiology in 1978 from the University of Arizona in Tucson. She then pursued an NIH-supported postdoctoral fellowship at the University of New Mexico School of Medicine in Albuquerque. In 1985, she published her first paper related to T-cell subset changes in HIV patients and acquired her own independent NIH funding. She has maintained continuous NIH funding since 1985, experiencing both times of multiple grants and times of reduced funding. She is former chair of the AIDS Immunology and Pathogenesis study section (2009-2011).

This Webinar presentation is brought to you as a training tool by the Principal Investigators Association, which is an independent organization. The presentation, tools presented and their contents are not connected with the National Institutes of Health (NIH), nor are they endorsed by this agency. All views expressed are those personally held by the presenter and are not official government policies or opinions.